- Home
- BME vs KURA Comparison
BME vs KURA Comparison
Compare BME & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BME
- KURA
- Stock Information
- Founded
- BME 2005
- KURA 2014
- Country
- BME United States
- KURA United States
- Employees
- BME N/A
- KURA N/A
- Industry
- BME Trusts Except Educational Religious and Charitable
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BME Finance
- KURA Health Care
- Exchange
- BME Nasdaq
- KURA Nasdaq
- Market Cap
- BME N/A
- KURA 592.7M
- IPO Year
- BME N/A
- KURA N/A
- Fundamental
- Price
- BME $38.41
- KURA $6.52
- Analyst Decision
- BME
- KURA Strong Buy
- Analyst Count
- BME 0
- KURA 10
- Target Price
- BME N/A
- KURA $25.50
- AVG Volume (30 Days)
- BME 34.0K
- KURA 1.1M
- Earning Date
- BME 01-01-0001
- KURA 05-01-2025
- Dividend Yield
- BME 6.26%
- KURA N/A
- EPS Growth
- BME N/A
- KURA N/A
- EPS
- BME 1.44
- KURA N/A
- Revenue
- BME N/A
- KURA $53,883,000.00
- Revenue This Year
- BME N/A
- KURA $13.15
- Revenue Next Year
- BME N/A
- KURA $221.86
- P/E Ratio
- BME $28.37
- KURA N/A
- Revenue Growth
- BME N/A
- KURA N/A
- 52 Week Low
- BME $35.53
- KURA $6.27
- 52 Week High
- BME $43.20
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- BME 36.39
- KURA 34.40
- Support Level
- BME $38.20
- KURA $6.95
- Resistance Level
- BME $38.88
- KURA $8.04
- Average True Range (ATR)
- BME 0.42
- KURA 0.40
- MACD
- BME -0.01
- KURA -0.08
- Stochastic Oscillator
- BME 29.66
- KURA 14.12
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.